FDA Approves LINEZOLID — Hospira, Inc.

Hospira, Inc. announced the FDA approval of its Linezolid Intravenous formulation, expanding the company's critically important portfolio of antibiotics and signaling an anticipated increase in market share against competing drugs. The approval is expected to drive growth in the hospital anti-infectives sector by providing clinicians with an additional intravenous option for treating serious Gram-positive bacterial infections.